Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis

Published:2009-11 Issue:11 Volume:33 Page:1481-1484
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Vega-Ruiz Arturo,Cortes Jorge E.,Sever Matjaz,Manshouri Taghi,Quintás-Cardama Alfonso,Luthra Raja,Kantarjian Hagop M.,Verstovsek Srdan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference11 articles.

1. Mastocytosis: state of the art;Horny;Pathobiology,2007

2. Kit: molecule of interest for the diagnosis and treatment of mastocytosis and other neoplastic disorders;Patnaik;Curr Cancer Drug Target,2007

3. Identifications of mutations in the coding sequence of the proto-oncogen c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product;Furitsu;J Clin Invest,1993

4. Novel approaches in the treatment of systemic mastocytosis;Quintas-Cardama;Cancer,2006

5. The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations;Ma;Blood,2002

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Advanced Systemic Mastocytosis: Clinical Challenges;Journal of Blood Medicine;2024-09

2. Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow;Clinical Lymphoma Myeloma and Leukemia;2024-07

3. Лечение агрессивного системного мастоцитоза и тучноклеточного лейкоза. Обзор литературы и серия клинических наблюдений;Clinical Oncohematology;2024-04-01

4. A case of indolent systemic mastocytosis responding to treatment with Avapritinib;Clinical Case Reports;2024-02

5. Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment;Genes;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3